Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab ...
US initiative follows recent CE certification of Ciliatech’s flagship eye implant, Intercil® Uveal Spacer, novel treatment for patients with mild to moderate glaucomaDecisive move unlocks ...
Black Book’s 2026 international survey of 210 health executives highlights a regional push to replace legacy interoperability engines with open, future-proof data architectures. BARCELONA, ES / ACCESS ...
MSP-Driven Talent Pools and AI-Powered Skill Matching: A Predictive Model for Clinical Trial Staffin
Clinical trials are the cornerstone of medical innovation, playing a vital role in advancing health care and developing new ...
Carbon 6, a new STEM sixth form at Discovery Park, opens in September 2026 offering A-levels in science and maths with ...
Long-term data on the treatment of children and adults living with Lennox-Gastaut syndrome (LGS) with fenfluramine1 demonstrated sustained reduction in frequency of seizures associated with a fall and ...
Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) is the first and only vaccine approved in this population in ChinaApproval adds to existing indication in adults aged 50 and overApproximately six ...
Cell Therapy Market Expansion Fueled by Rising Adoption of Stem Cell and Gene-Based Therapies WorldwideGlobal Cell Therapy ...
Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs), will present new data from its Phase 1 study of IKS014, a human epidermal growth factor receptor 2 (HER2) ...
Innovation Meets Affordability: Global Generic Drugs Market Poised for Transformative Growth by 2035
Innovation and Accessibility Fuel the Growth of the Global Generic Drugs MarketThe Global Generic Drugs Market is valued at ...
The aspiration and biopsy needles market represents a critical segment within the global medical devices industry, ...
Overview of Healthcare Chatbots MarketThe global Healthcare Chatbots Market is valued at USD 1.2 Billion in 2024 and is projected to reach a value of USD 12.57 Billion by 2035 at a CAGR (Compound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results